2012
DOI: 10.1111/j.1365-2133.2011.10593.x
|View full text |Cite
|
Sign up to set email alerts
|

Molecular genetic support for the rule of dichotomy in type 2 segmental Darier disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
28
0
3

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(31 citation statements)
references
References 12 publications
0
28
0
3
Order By: Relevance
“…1 In type 2 mosaicism, a heterozygous embryo harbours a germline mutation for an autosomal dominant skin disease, and a segmental area of the skin that is far more severely affected as a result of loss of heterozygosity for the underlying mutation, giving rise to either homozygosity or hemizygosity. 3,4 Here we report a patient with congenital, pronounced, unilateral lesions of Gorlin syndrome (naevoid basal cell carcinoma syndrome, OMIM 109400), and we present, for the first time, molecular data providing evidence of a type 2 segmental manifestation of this autosomal dominant disorder. 2 To date, however, molecular proof of the concept has been provided in only a few skin disorders.…”
mentioning
confidence: 90%
See 1 more Smart Citation
“…1 In type 2 mosaicism, a heterozygous embryo harbours a germline mutation for an autosomal dominant skin disease, and a segmental area of the skin that is far more severely affected as a result of loss of heterozygosity for the underlying mutation, giving rise to either homozygosity or hemizygosity. 3,4 Here we report a patient with congenital, pronounced, unilateral lesions of Gorlin syndrome (naevoid basal cell carcinoma syndrome, OMIM 109400), and we present, for the first time, molecular data providing evidence of a type 2 segmental manifestation of this autosomal dominant disorder. 2 To date, however, molecular proof of the concept has been provided in only a few skin disorders.…”
mentioning
confidence: 90%
“…2 To date, however, molecular proof of the concept has been provided in only a few skin disorders. 3,4 Here we report a patient with congenital, pronounced, unilateral lesions of Gorlin syndrome (naevoid basal cell carcinoma syndrome, OMIM 109400), and we present, for the first time, molecular data providing evidence of a type 2 segmental manifestation of this autosomal dominant disorder.…”
mentioning
confidence: 90%
“…AKV is considered to be allelic to DD, since ATP2A2 mutations have been found in patients with AKV [Dhitavat et al, 2003b]. DD and HHD may occur in a segmental distribution, either due to a postzygotic somatic mutation (type I segmental disease) [Sakuntabhai et al, 2000] or postzygotic loss of heterozygosity for the wild-type allele in a patient heterozygous for a germline ATP2A2 mutation (type II segmental disease) [Fölster-Holst et al, 2012].…”
Section: Introductionmentioning
confidence: 99%
“…To date more than 187 pathogenic mutations have been described throughout the gene, including missense, nonsense, substitutions, insertions and deletions both frame‐shift and in‐frame (Miyauchi et al., for all references 2006 and earlier, and subsequent references). These mutations do not seem to cluster within “hot‐spot” regions throughout the primary sequence of the SERCA2b molecule and most are unique within individual families.…”
Section: Introductionmentioning
confidence: 99%